Literature DB >> 18068491

The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome.

Yukari C Manabe1, Anup K Kesavan, Javier Lopez-Molina, Christine L Hatem, Megan Brooks, Ricardo Fujiwara, Karl Hochstein, M Louise M Pitt, Joann Tufariello, John Chan, David N McMurray, William R Bishai, Arthur M Dannenberg, Susana Mendez.   

Abstract

The large reservoir of human latent tuberculosis (TB) contributes to the global success of the pathogen, Mycobacterium tuberculosis (Mtb). We sought to test whether aerosol infection of rabbits with Mtb H37Rv could model paucibacillary human latent TB. The lung burden of infection peaked at 5 weeks after aerosol infection followed by host containment of infection that was achieved in all rabbits. One-third of rabbits had at least one caseous granuloma with culturable bacilli at 36 weeks after infection suggesting persistent paucibacillary infection. Corticosteroid-induced immunosuppression initiated after disease containment resulted in reactivation of disease. Seventy-two percent of rabbits had culturable bacilli in the right upper lung lobe homogenates compared to none of the untreated controls. Discontinuation of dexamethasone led to predictable lymphoid recovery, with a proportion of rabbits developing multicentric large caseous granuloma. The development and severity of the immune reconstitution inflammatory syndrome (IRIS) was dependent on the antigen load at the time of immunosuppression and subsequent bacillary replication during corticosteroid-induced immunosuppression. Clinically, many aspects were similar to IRIS in severely immunosuppressed HIV-infected patients who have functional restoration of T cells in response to effective (highly active) antiretroviral therapy. This corticosteroid model is the only animal model of the IRIS. Further study of the rabbit model of TB latency, reactivation and IRIS may be important in understanding the immunopathogenesis of these poorly modeled states as well as for improved diagnostics for specific stages of disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068491      PMCID: PMC4477206          DOI: 10.1016/j.tube.2007.10.006

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  21 in total

1.  The bacteriology of respected tuberculous pulmonary lesions. 2. Observations on bacilli which are stainable but which cannot be cultured.

Authors:  L G WAYNE
Journal:  Am Rev Respir Dis       Date:  1960-09

2.  Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice.

Authors:  Eleanor Roy; Evangelos Stavropoulos; John Brennan; Stephen Coade; Elena Grigorieva; Barry Walker; Belinda Dagg; Ricardo E Tascon; Douglas B Lowrie; M Joseph Colston; Stephen Jolles
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2007-01-30       Impact factor: 4.177

4.  A bacteriologic study of resected tuberculous lesions.

Authors:  E M MEDLAR; S BERNSTEIN; D M STEWARD
Journal:  Am Rev Tuberc       Date:  1952-07

5.  Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

Authors:  M Narita; D Ashkin; E S Hollender; A E Pitchenik
Journal:  Am J Respir Crit Care Med       Date:  1998-07       Impact factor: 21.405

6.  Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?

Authors:  Ronan A M Breen; Colette J Smith; Ian Cropley; Margaret A Johnson; Marc C I Lipman
Journal:  AIDS       Date:  2005-07-22       Impact factor: 4.177

7.  B-lymphocytes and co-stimulatory molecules in Mycobacterium tuberculosis infection.

Authors:  M Corominas; V Cardona; L Gonzalez; J A Caylà; G Rufi; M Mestre; E Buendia
Journal:  Int J Tuberc Lung Dis       Date:  2004-01       Impact factor: 2.373

8.  Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits.

Authors:  Susan E Dorman; Christine L Hatem; Sandeep Tyagi; Katherine Aird; Javier Lopez-Molina; M Louise M Pitt; Bernard C Zook; Arthur M Dannenberg; William R Bishai; Yukari C Manabe
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis.

Authors:  Yukari C Manabe; Arthur M Dannenberg; Sandeep K Tyagi; Christine L Hatem; Mark Yoder; Samuel C Woolwine; Bernard C Zook; M Louise M Pitt; William R Bishai
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli.

Authors:  R M McCune; F M Feldmann; W McDermott
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

View more
  48 in total

1.  Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.

Authors:  Ying Kong; Hequan Yao; Hongjun Ren; Selvakumar Subbian; Suat L G Cirillo; James C Sacchettini; Jianghong Rao; Jeffrey D Cirillo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 2.  Animal Models for Tuberculosis in Translational and Precision Medicine.

Authors:  Lingjun Zhan; Jun Tang; Mengmeng Sun; Chuan Qin
Journal:  Front Microbiol       Date:  2017-05-04       Impact factor: 5.640

3.  A screen for non-coding RNA in Mycobacterium tuberculosis reveals a cAMP-responsive RNA that is expressed during infection.

Authors:  Shaaretha Pelly; William R Bishai; Gyanu Lamichhane
Journal:  Gene       Date:  2012-03-15       Impact factor: 3.688

4.  Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.

Authors:  Emily R Driver; Gavin J Ryan; Donald R Hoff; Scott M Irwin; Randall J Basaraba; Igor Kramnik; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

Review 5.  Opening Pandora's Box: Mechanisms of Mycobacterium tuberculosis Resuscitation.

Authors:  Ashley V Veatch; Deepak Kaushal
Journal:  Trends Microbiol       Date:  2017-09-11       Impact factor: 17.079

Review 6.  Immunological roulette: Luck or something more? Considering the connections between host and environment in TB.

Authors:  John E Pearl; Mrinal Das; Andrea M Cooper
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 7.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

8.  The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis.

Authors:  Léanie Kleynhans; Nelita Du Plessis; Nasiema Allie; Muazzam Jacobs; Martin Kidd; Paul D van Helden; Gerhard Walzl; Katharina Ronacher
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

9.  Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus).

Authors:  Laura E Via; Danielle M Weiner; Daniel Schimel; Philana Ling Lin; Emmanuel Dayao; Sarah L Tankersley; Ying Cai; M Teresa Coleman; Jaime Tomko; Praveen Paripati; Marlene Orandle; Robin J Kastenmayer; Michael Tartakovsky; Alexander Rosenthal; Damien Portevin; Seok Yong Eum; Saher Lahouar; Sebastien Gagneux; Douglas B Young; Joanne L Flynn; Clifton E Barry
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

10.  REMap: Operon map of M. tuberculosis based on RNA sequence data.

Authors:  Shaaretha Pelly; Kathryn Winglee; Fang Fang Xia; Rick L Stevens; William R Bishai; Gyanu Lamichhane
Journal:  Tuberculosis (Edinb)       Date:  2016-04-29       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.